Defined as persistent clinical or electroencephalographic seizures despite adequate doses of benzodiazepines and standard antiepileptic drugs.
The primary goal of this research was to investigate the incidence, triggers, and long-term outcomes of status epilepticus (SE) within the specific context of autoimmune encephalitis (AE). While 80% of AE patients generally recover well (Modified Rankin Score 0–2) with early immunotherapy, the subset that develops SE faces significantly higher risks. Miras-Amanat-E19601:04:57 Min
Early initiation of immunotherapy is the most reliable predictor of a positive clinical outcome. Miras-Amanat-E19601:04:57 Min
Evaluation of Predisposing Factors and Prognostic Risk Factors for Status Epilepticus (SE) in Patients with Autoimmune Encephalitis (AE). 1. Core Objective Miras-Amanat-E19601:04:57 Min